1. Miller, C. S. & Redding, S. W. Diagnosis and management of orofacial herpes simplex virus infections. Dent. Clin. North. Am. 36, 879–895 (1992).
2. Marchi, S., Trombetta, C. M., Gasparini, R., Temperton, N. & Montomoli, E. Epidemiology of herpes simplex virus type 1 and 2 in Italy: a seroprevalence study from 2000 to 2014. J. Prev. Med. Hyg. 58, E27–E33 (2017).
3. Lim, F., Khalique, H., Ventosa, M. & Baldo, A. Biosafety of gene therapy vectors derived from herpes simplex virus type 1. Curr. Gene. Ther. 13, 478–491 (2013).
4. Filip, L. HSV-1 as a Model for Emerging Gene Delivery Vehicles. ISRN Virology 2013, 397243 (2013).
5. Grant, K. G., Krisky, D. M., Ataai, M. M. & Glorioso, J. C. Engineering cell lines for production of replication defective HSV-1 gene therapy vectors. Biotechnol. Bioeng. 102, 1087–1097 (2009).